Natalizumab in secondary progressive multiple sclerosis

Abstract : Although several disease-modifying treatments are available for relapsing types of multiple sclerosis, additional treatment options for progressive types of multiple sclerosis are needed, especially since the available treatments tend to focus on patients who are actively relapsing...
Document type :
Journal articles
Complete list of metadatas

Cited literature [10 references]  Display  Hide  Download

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01876097
Contributor : Laurent Jonchère <>
Submitted on : Tuesday, September 18, 2018 - 10:44:19 AM
Last modification on : Friday, April 12, 2019 - 10:36:08 AM
Long-term archiving on : Wednesday, December 19, 2018 - 1:04:18 PM

File

Edan_Natalizumab in secondary ...
Files produced by the author(s)

Identifiers

Citation

Gilles Edan. Natalizumab in secondary progressive multiple sclerosis. Lancet Neurology, Elsevier, 2018, 17 (5), pp.384 - 385. ⟨10.1016/S1474-4422(18)30108-X⟩. ⟨hal-01876097⟩

Share

Metrics

Record views

76

Files downloads

113